Independent physicians and clinic owners are uniquely positioned to deliver medically supervised GLP-1 weight loss in a way that prioritizes the patient not the platform
Preparations approved by FDA or EMA should be selected
These hormones are part of the gut-brain axis, and their respective receptors are often present in the periphery as well as in the brain. Elucidating the pathways and processes through which GLP-1 and similar hormones modulate weight loss may allow for the finetuning and evolution of novel therapeutic interventions against obesity, which, if left unchecked, is expected to impact more than half the worlds human population by 2035
Koska J, Sands M, Burciu C, DSouza KM, Raravikar K, Liu J, Truran S, Franco DA, Schwartz EA, Schwenke DC, et al
Sports Nutrition 4.3.7